Cargando…

Cluster Gauss‐Newton method analyses of PBPK model parameter combinations of coproporphyrin‐I based on OATP1B‐mediated rifampicin interaction studies

Coproporphyrin I (CP‐I) is an endogenous biomarker supporting the prediction of drug–drug interactions (DDIs) involving hepatic organic anion transporting polypeptide 1B (OATP1B). We previously constructed a physiologically‐based pharmacokinetic (PBPK) model for CP‐I using clinical DDI data with an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshikado, Takashi, Aoki, Yasunori, Mochizuki, Tatsuki, Rodrigues, A. David, Chiba, Koji, Kusuhara, Hiroyuki, Sugiyama, Yuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574750/ https://www.ncbi.nlm.nih.gov/pubmed/35945914 http://dx.doi.org/10.1002/psp4.12849

Ejemplares similares

PBPK Modeling of Coproporphyrin I as an Endogenous Biomarker for Drug Interactions Involving Inhibition of Hepatic OATP1B1 and OATP1B3
por: Yoshikado, Takashi, et al.
Publicado: (2018)

Physiologically‐based pharmacokinetic model‐based translation of OATP1B‐mediated drug–drug interactions from coproporphyrin I to probe drugs
por: Mochizuki, Tatsuki, et al.
Publicado: (2022)

Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug‐Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects
por: Asaumi, Ryuta, et al.
Publicado: (2018)

Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs
por: Mori, Daiki, et al.
Publicado: (2020)

Performance of Plasma Coproporphyrin I and III as OATP1B1 Biomarkers in Humans
por: Neuvonen, Mikko, et al.
Publicado: (2021)

Quantification of OATP1B1 endogenous metabolites coproporphyrin I and III in human urine
por: Jang, Yeonseo, et al.
Publicado: (2023)

Relationship of hemoglobin level and plasma coproporphyrin‐I concentrations as an endogenous probe for phenotyping OATP1B
por: Suzuki, Yosuke, et al.
Publicado: (2021)

Diffeomorphic registration using geodesic shooting and Gauss–Newton optimisation
por: Ashburner, John, et al.
Publicado: (2011)

Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease
por: Takita, Hiroyuki, et al.
Publicado: (2022)

PBPK Model of Coproporphyrin I: Evaluation of the Impact of SLCO1B1 Genotype, Ethnicity, and Sex on its Inter‐Individual Variability
por: Takita, Hiroyuki, et al.
Publicado: (2021)

Substantially Increased Plasma Coproporphyrin‐I Concentrations Associated With OATP1B1*15 Allele in Japanese General Population
por: Suzuki, Yosuke, et al.
Publicado: (2020)

An Analysis on Local Convergence of Inexact Newton-Gauss Method for Solving Singular Systems of Equations
por: Zhou, Fangqin
Publicado: (2014)

Adaptive stochastic Gauss–Newton method with optical Monte Carlo for quantitative photoacoustic tomography
por: Hänninen, Niko, et al.
Publicado: (2022)

Coproporphyrin I Can Serve as an Endogenous Biomarker for OATP1B1 Inhibition: Assessment Using a Glecaprevir/Pibrentasvir Clinical Study
por: Kalluri, Hari V., et al.
Publicado: (2020)

Gaining Mechanistic Insight Into Coproporphyrin I as Endogenous Biomarker for OATP1B‐Mediated Drug–Drug Interactions Using Population Pharmacokinetic Modeling and Simulation
por: Barnett, Shelby, et al.
Publicado: (2018)

Crystal structures and calorimetry reveal catalytically relevant binding mode of coproporphyrin and coproheme in coproporphyrin ferrochelatase
por: Hofbauer, Stefan, et al.
Publicado: (2019)

Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions
por: Mochizuki, Tatsuki, et al.
Publicado: (2022)

Prediction of the Pharmacokinetics of Pravastatin as an OATP Substrate Using Plateable Human Hepatocytes With Human Plasma Data and PBPK Modeling
por: Mao, Jialin, et al.
Publicado: (2018)

Active site architecture of coproporphyrin ferrochelatase with its physiological substrate coproporphyrin III: Propionate interactions and porphyrin core deformation
por: Dali, Andrea, et al.
Publicado: (2023)

Application of a PBPK model to elucidate the changes of systemic and liver exposures for rosuvastatin, carotegrast, and bromfenac followed by OATP inhibition in monkeys
por: Cheng, Yaofeng, et al.
Publicado: (2021)

Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
por: Montanha, Maiara Camotti, et al.
Publicado: (2021)

Correction to: Predicting Drug–Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling
por: Montanha, Maiara Camotti, et al.
Publicado: (2022)

Various effects of repeated rifampin dosing on coproporphyrin levels in humans
por: Kinzi, Jonny, et al.
Publicado: (2023)

Expanded Physiologically‐Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction
por: Asaumi, Ryuta, et al.
Publicado: (2019)

Gauß: eine Biographie
por: Mania, Hubert
Publicado: (2009)

Gauss and Jacobi sums
por: Berndt, Bruce C, et al.
Publicado: (1998)

Cusps of Gauss Mappings
por: Banchoff, Thomas, et al.
Publicado: (1982)

Iteratively regularized Gauss–Newton type methods for approximating quasi–solutions of irregular nonlinear operator equations in Hilbert space with an application to COVID–19 epidemic dynamics()
por: Kokurin, M.M., et al.
Publicado: (2022)

Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
por: Yoshida, Kenta, et al.
Publicado: (2013)

Cell-to-Medium Concentration Ratio Overshoot in the Uptake of Statins by Human Hepatocytes in Suspension, but Not in Monolayer: Kinetic Analysis Suggesting a Partial Loss of Functional OATP1Bs
por: Lee, Wooin, et al.
Publicado: (2020)

Propionibacterium-Produced Coproporphyrin III Induces Staphylococcus aureus Aggregation and Biofilm Formation
por: Wollenberg, Michael S., et al.
Publicado: (2014)

Newton.
Publicado: (1982)

Newton
Publicado: (1982)

Newton
por: Christianson, Gale E.
Publicado: (1986)

Physiologically‐based pharmacokinetic modeling for investigating the effect of simeprevir on concomitant drugs and an endogenous biomarker of OATP1B
por: Nakayama, Shinji, et al.
Publicado: (2023)

More Power to OATP1B1: An Evaluation of Sample Size in Pharmacogenetic Studies Using a Rosuvastatin PBPK Model for Intestinal, Hepatic, and Renal Transporter‐Mediated Clearances
por: Emami Riedmaier, Ariane, et al.
Publicado: (2016)

Geometry of the generalized Gauss map
por: Osman, Robert, et al.
Publicado: (1980)

Gauss: a biographical study
por: Bühler, W K
Publicado: (1981)

Newton's apple: Isaac Newton and the English scientific renaissance
por: Aughton, Peter
Publicado: (2003)

The coproporphyrin ferrochelatase of Staphylococcus aureus: mechanistic insights into a regulatory iron-binding site
por: Hobbs, Charlie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v5cmvfgm5s0o6c221o9j6lnaqv